Indian equity markets ended Friday’s session on a strong note, snapping a four-day losing streak, but investors are likely to shift their attention to key domestic data, currency movements and global ...
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback